Thyreotoxische Krise und Myxödemkoma

Abstract

Thyroid storm and myxedema coma are the most severe clinical forms of thyroid dysfunction. While both hyper- and hypothyroidsm are common diseases, thyroid storm and myxedema coma are rare. Due to their unspecific signs and symptoms they are often difficult to diagnose. Both disorders are medical emergencies, which still show a significant mortality. The following article summarizes diagnostic tools and treatment options for these disorders

Die thyreotoxische Krise und das Myxödemkoma stellen lebensbedrohliche Verlaufsformen der Hyper- bzw. Hypothyreose dar. Sie sind jedoch nicht nur Extremformen eines klinischen Spektrums, sondern auch Entitäten mit eigenen Charakteristika. Die Abgrenzung zu noch kompensierten Formen ist unscharf und selbst bei suffizienter multimodaler Therapie gehen sie mit einer relevanten Mortalität einher.

Schlüsselwörter

Thyreotoxische Krise - Myxödemkoma - Funktionsstörungen der Schilddrüse

Key words

thyroid storm - myxedema - myxedema coma

• Literatur

• 1 Zender S, Dölle M, Terkamp C. et al. Intensivmedizinische Behandlung der thyreotoxischen Krise. Intensivmed.up2date 2016; 12: 291-302
• 2 Dietrich JW. Thyreotoxische Krise. Medizinische Klinik, Intensivmedizin und Notfallmedizin 2012; 107: 448-453
• 3 Akamizu T, Satoh T, Isozaki O. et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 2012; 22: 661-679
• 4 Satoh T, Isozaki O, Suzuki A. et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition). Endocrine journal 2016; 63: 1025-1064
• 5 Angell TE, Lechner MG, Nguyen CT. et al. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endocrinol Metab 2015; 100: 451-459
• 6 Ross DS, Burch HB, Cooper DS. et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016; 26: 1343-1421
• 7 Wilson S, Parle JV, Roberts LM. et al. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey. J Clin Endocrinol Metab 2006; 91: 4809-4816
• 8 Ono Y, Ono S, Yasunaga H. et al. Clinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan. Journal of epidemiology 2017; 27: 117-122
• 9 Dutta P, Bhansali A, Masoodi SR. et al. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care 2008; 12: R1
• 10 Chiong YV, Bammerlin E, Mariash CN. Development of an objective tool for the diagnosis of myxedema coma. Transl Res 2015; 166: 233-243
• 11 Ono Y, Ono S, Ysunaga H. et al. Clinical characteristics and outcome of myxedema coma: analysis of a ational inpatient database in Japan. Journal of Endocrinology 2017; 27: 117-122
• 12 Popoveniuc GChandra T, Sud A. et al. A diagnostic scoring system for myxedema coma. Endocr Pract 2015; 20: 808-817